Tag: B7-H3
Rapid Advances in the Development of Novel ADCs Targeting B7-H3 and...
With five antibody-drug conjugates (ADC) having received approval from the United States Food and Drug Administration (FDA) and other regulators around the world and...
MacroGenics and Synthon Biopharmaceuticals Sign Agreement
MacroGenics and Synthon Biopharmaceuticals have signed an agreement to license and collaborate in he development of MGC018, an antibody-drug conjugate or ADC directed against...